Coronavirus Disease (COVID)19 Clinical Trial
Official title:
D-dimer Adjusted Versus Therapeutic Dose Low-molecular-weight Heparin in Patients With COVID-19 Pneumonia
evaluation of the efficacy and safety of D-dimer adjusted heparin versus therapeutic dose heparin in patients with COVID-19 Pneumonia.
The following will be done for enrolled patients:
1. Data collection: name, age, sex, special habits of medical importance (i.e. smoking,
drug abuse), comorbid conditions.
2. Clinical examination Vital data Local chest examination
3. Measurement of oxygen saturation using pulse oximeter
4. Laboratory investigations:
Complete blood count with differential count Liver and kidney functions D-dimer level
Coagulation profile
5. Radiology work up ( Chest X-ray-High resolution computed tomography of the chest-
computed tomography of the chest with pulmonary angiography as needed)
6. Sepsis-induced coagulopathy score (SIC score)
7. Sequential organ failure score (SOFA score)
8. Patients will receive treatment according to the hospital guidelines for different
disease stratification severity
;